Update on Gastrointestinal Stromal Tumors for Radiologists

The management of gastrointestinal stromal tumors (GISTs) has evolved significantly in the last two decades due to better understanding of their biologic behavior as well as development of molecular targeted therapies. GISTs with exon 11 mutation respond to imatinib whereas GISTs with exon 9 or succ...

Descripción completa

Detalles Bibliográficos
Autores principales: Tirumani, Sree Harsha, Baheti, Akshay D., Tirumani, Harika, O'Neill, Ailbhe, Jagannathan, Jyothi P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Radiology 2017
Materias:
Cancer Imaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240484/
https://www.ncbi.nlm.nih.gov/pubmed/28096720
http://dx.doi.org/10.3348/kjr.2017.18.1.84

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240484/
https://www.ncbi.nlm.nih.gov/pubmed/28096720
http://dx.doi.org/10.3348/kjr.2017.18.1.84

Ejemplares similares